NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment

  1. Sánchez-Herrero, E.
  2. Serna-Blasco, R.
  3. Ivanchuk, V.
  4. García-Campelo, R.
  5. Dómine Gómez, M.
  6. Sánchez, J.M.
  7. Massutí, B.
  8. Reguart, N.
  9. Camps, C.
  10. Sanz-Moreno, S.
  11. Calabuig-Fariñas, S.
  12. Jantus-Lewintre, E.
  13. Arnal, M.
  14. Fernández-Orth, D.
  15. Calvo, V.
  16. González-Rumayor, V.
  17. Provencio, M.
  18. Romero, A.
Journal:
Molecular Oncology

ISSN: 1878-0261 1574-7891

Year of publication: 2021

Volume: 15

Issue: 9

Pages: 2363-2376

Type: Article

DOI: 10.1002/1878-0261.13033 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals